Related Experiment Video

Updated: Sep 30, 2026

Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes
08:45

Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes

Published on: May 10, 2022

Iron status and the treatment of the anemia of prematurity

Pamela J Kling1, Joy J Winzerling

  • 1Department of Pediatrics, Steele Memorial Children's Research Center, 1501 N. Campbell Ave., PO # 24-5073, The University of Arizona, Tucson, AZ 85724-5073, USA. pkling@facstaff.wisc.edu

Clinics in Perinatology
|August 10, 2002
PubMed

Insights

Recombinant human erythropoietin (rhEPO) therapy in premature infants requires further study to determine optimal use, long-term effects on transfusions and iron status, and safety of iron supplementation.

Area of Science:

  • Neonatal Medicine
  • Hematology
  • Pharmacology

Background:

  • Erythropoiesis-stimulating agents like recombinant human erythropoietin (rhEPO) are used in preterm infants.
  • Significant questions persist regarding the optimal application and outcomes of rhEPO therapy in this population.

Purpose of the Study:

  • To identify key areas needing further investigation for rhEPO therapy in premature infants.
  • To address uncertainties surrounding patient selection, transfusion reduction, nutritional support, and iron status.

Main Methods:

  • This study is a review of existing literature and clinical practice.
  • It highlights areas for future research based on current knowledge gaps.

Main Results:

  • Optimal patient responders to rhEPO therapy are not clearly defined.
  • Long-term effects of reduced erythrocyte transfusions and the role of nutritional supplementation require further elucidation.
  • The potential for rhEPO therapy to cause later-life iron deficiency and the safety of parenteral iron supplementation remain critical research questions.

Conclusions:

  • Further research is essential to optimize rhEPO therapy in preterm infants.
  • Understanding iron status and the safety of iron supplementation alongside rhEPO is crucial for improving neonatal care.

More Related Videos

A Point-of-Care Method with Integrated Decision Support Tool to Estimate Anemia at Population Level05:35

A Point-of-Care Method with Integrated Decision Support Tool to Estimate Anemia at Population Level

Published on: January 19, 2024

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload05:23

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

Related Concept Videos

Rh Blood Group01:19

Rh Blood Group

The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Factors Affecting Erythropoiesis01:24

Factors Affecting Erythropoiesis

The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Erythropoiesis01:14

Erythropoiesis

Red blood cells  (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia, and...